Table 2.
Mean and standard deviation of atherogenic, inflammatory indices, and serum taurine levels of participants in different phases.
| Variables | Taurine |
Placebo | ||||||
|---|---|---|---|---|---|---|---|---|
| Pre-Exer, Pre-Suppl | Post-Exer, Pre-Suppl | Pre-Exer, Post-Suppl | Post-Exer, Post-Suppl | Pre-Exer, Pre-Suppl | Post-Exer, Pre-Suppl | Pre-Exer, Post-Suppl | Post-Exer, Post-Suppl | |
| Atherogenic indices | ||||||||
| CRI-I (TC/HDL-c) | 4.9339 ± 0.15369 | 4.8451 ± 0.19662 | 3.5096 ± 0.13026 | 3.5230 ± 0.14851 | 4.3843 ± 0.13291 | 4.3499 ± 0.17403 | 4.6915 ± 0.22184 | 4.7464 ± 0.21539 |
| CRI-II (LDL-c/HDL-c) | 3.5398 ± 0.26571 | 3.5961 ± 0.26849 | 2.4201 ± 0.08174 | 2.5271 ± 0.6772 | 3.4126 ± 0.16529 | 3.5175 ± 0.38527 | 3.7971 ± 0.26640 | 3.9813 ± 0.20190 |
| AC (triglyceride/HDL-c) | 4.0034 ± 0.13330 | 3.9840 ± 0.19288 | 3.0680 ± 0.14558 | 3.0491 ± 0.09942 | 3.4925 ± 0.11901 | 3.5157 ± 0.12589 | 4.2010 ± 0.22570 | 4.2635 ± 0.14096 |
| Inflammatory indices | ||||||||
| CRP (pg/ml) | 617.5 ± 12.35 | 647.25 ± 14.38 | 491.88 ± 17.22 | 521 ± 13.18 | 647.87 ± 14.11 | 681.5 ± 11.61 | 709.25 ± 15.17 | 733.87 ± 14.44 |
| Platelet (µmol/l) | 185.75 ± 19.53 | 186.75 ± 19.38 | 175.87 ± 22.27 | 174.62 ± 14.76 | 162.75 ± 6.29 | 173.87 ± 21.83 | 190.75 ± 20.82 | 192 ± 17.53 |
| Taurine (µmol/l) | 58.88 ± 19.64 | 59.87 ± 12.97 | 140.5 ± 20.12 | 111 ± 25.37 | 44.13 ± 9.19 | 42 ± 8.14 | 61.63 ± 13.29 | 49.1 ± 10.42 |
AC, atherogenic coefficient; CRI-I, Castelli’s Risk Index-I; CRI-II, Castelli’s Risk Index-II; CRP, C-reactive protein; Exer, exercise; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; TC, total cholesterol; Suppl, supplementation.